Arteriosclerosis Thrombosis and Vascular Biology · 2007 · 80 citations · 32 references
PharmacyImmunologyPathobiologyImmunizationImmunotherapyVaccinologyAngiogenesisDna VaccinesImmune Response To VaccinationTherapeutic VaccinationVaccinationVector-based VaccinesAtherosclerosis RiskAtherosclerotic ProgressionCd8 Positive T CellsDeoxyribonucleic Acid (Dna) VaccineDna Vector VaccinesInfectious Disease VaccinesVascular Endothelial Growth FactorVascular Endothelial Growth Factor Receptor Signaling
OBJECTIVE: Vascular endothelial growth factor receptor 2 (VEGFR2)-overexpressing cells may form an interesting target for the treatment of atherosclerosis because of their involvement in processes that contribute to this disease, such as angiogenesis. METHODS AND RESULTS: We vaccinated mice against VEGFR2 by an orally administered DNA vaccine, comprising a plasmid, encoding murine VEGFR2, carried by live attenuated Salmonella typhimurium. This vaccine induces cellular immunity against cells that overexpress VEGFR2. Vaccination of hypercholesterolemic mice against VEGFR2 resulted in a marked induction of CD8+ cytotoxic T cells specific for VEGFR2 and led to an inhibition of angiogenesis in a hindlimb ischemia model. Interestingly, VEGFR2 vaccination attenuated the progression of preexisting advanced atherosclerotic lesions in the brachiocephalic artery of apoE-/- mice. Furthermore, VEGFR2 vaccination strongly reduced the initiation of collar-induced atherosclerosis in the carotid arteries of LDLr-/- mice. In addition, denudation of the carotid artery, as a model for postinterventional lesion formation, resulted in delayed endothelial replacement and significantly increased neointima formation on VEGFR2 vaccination. CONCLUSIONS: These data indicate the prominent role of VEGFR2+ cells in cardiovascular diseases and show that induction of cellular immunity against atherosclerosis-associated cells by means of DNA vaccination may contribute to the development of novel therapies against atherosclerosis.
32
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Fouad Shalaby, Janet Rossant, Terry P. Yamaguchi et al. · Nature · 1995 · 3.9K citations
Evidence for Circulating Bone Marrow-Derived Endothelial Cells
Qun Shi, Shahin Rafii, Moses Hong-De Wu et al. · Blood · 1998 · 1.7K citations
Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors
Jun K. Yamashita, Hiroshi Itoh, Masanori Hirashima et al. · Nature · 2000 · 1.4K citations
Natural regulatory T cells control the development of atherosclerosis in mice
Hafid Ait‐Oufella, Benoı̂t L. Salomon, Stéphane Potteaux et al. · Nature Medicine · 2006 · 1.1K citations
Life Sciences, Immunology, Pathology +12